UbiVac
Home Collaboration Investors Contact
New Index
Overview Executive Leadership Board of Directors Advisory Board
Technologies Pipeline
Presentations Publications Press Releases In the News
Home About Overview Executive Leadership Board of Directors Advisory Board Research & Pipeline Technologies Pipeline CollaborationInvestors Newsroom Presentations Publications Press Releases In the News Contact
UbiVac
New Index

Adoptive TIL in HPV-negative Oral SCCA

Rom Leidner, Brendan D Curti, Roxanne M Payne, Walter Urba, Keith S Bahjat, Yoshinobu Koguchi, Krista Nelson, Jennifer A Moore, Marka Crittenden, Yedeh Ying, Ashish Patel, Allen Cheng, Tuan G Bui, Traci Hilton, Christopher Paustian, Sachin Puri, Hong Ming Hu, Carlo Bifulco, Zipei Feng, R Bryan Bell and Bernard Fox

Journal for ImmunoTherapy of Cancer, Vol 3, Suppl 2, November 4, 2015

Bernie FoxJune 4, 2018
Facebook0 Twitter 0 Likes
Previous

Preliminary Analysis of Immune Responses in Patients Enrolled in a Phase II Trial of Cyclophosphamide with Allogenic DRibble Vaccine Alone (DPV-001) or with GM-CSF or Imiquimod

Bernie FoxJune 4, 2018
Next

Cross-presentation of Viral Antigens in DRibbles Leads to Efficient Activation of Virus-specific Human Memory T Cells

Bernie FoxJune 4, 2018

© 2020 UbiVac | All rights reserved.